{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:51:56Z","timestamp":1769752316443,"version":"3.49.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2020M3E5D9080165"],"award-info":[{"award-number":["NRF-2020M3E5D9080165"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2022R1F1A1074517"],"award-info":[{"award-number":["NRF-2022R1F1A1074517"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004080","name":"Korea Drug Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2021-DD120983"],"award-info":[{"award-number":["RS-2021-DD120983"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.neuropharm.2024.110045","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T06:09:07Z","timestamp":1718431747000},"page":"110045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Neonatal dysregulation of 2-arachidonoylglycerol induces impaired brain function in adult mice"],"prefix":"10.1016","volume":"257","author":[{"given":"Kyung-Jun","family":"Boo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunbi","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0540-4739","authenticated-orcid":false,"given":"Dong Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Jin","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110045_bib1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4062\/biomolther.2021.194","article-title":"Behavioral deficits in adolescent mice after sub-chronic administration of NMDA during early stage of postnatal development","volume":"30","author":"Adil","year":"2022","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.neuropharm.2024.110045_bib2","doi-asserted-by":"crossref","first-page":"23892","DOI":"10.1074\/jbc.M700678200","article-title":"The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis","volume":"282","author":"Aguado","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2024.110045_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1523\/JNEUROSCI.3973-07.2008","article-title":"Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice","volume":"28","author":"Ansorge","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13229-019-0256-6","article-title":"Lower circulating endocannabinoid levels in children with autism spectrum disorder","volume":"10","author":"Aran","year":"2019","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuropharm.2024.110045_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2018.05.002","article-title":"2-Arachidonoylglycerol: a signaling lipid with manifold actions in the brain","volume":"71","author":"Baggelaar","year":"2018","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.neuropharm.2024.110045_bib6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/cercor\/bhp133","article-title":"Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning","volume":"20","author":"Balschun","year":"2010","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2024.110045_bib7","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1210\/en.2004-1142","article-title":"Strategies and methods for research on sex differences in brain and behavior","volume":"146","author":"Becker","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2024.110045_bib8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00406-020-01191-2","article-title":"Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study","volume":"271","author":"Borgan","year":"2021","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib9","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.3390\/ijms23105526","article-title":"Modulation of endocannabinoid system components in depression: pre-clinical and clinical evidence","volume":"23","author":"Bright","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.bjp.0707584","article-title":"CB 2 receptors in the brain: role in central immune function","volume":"153","author":"Cabral","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.neubiorev.2005.04.017","article-title":"Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on","volume":"29","author":"Carobrez","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2024.110045_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2018.00479","article-title":"Inhibition of diacylglycerol lipase impairs fear extinction in mice","volume":"12","author":"Cavener","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jpsychires.2012.03.021","article-title":"Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear","volume":"46","author":"Choi","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2024.110045_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.neuron.2006.08.033","article-title":"Arc\/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking","volume":"52","author":"Chowdhury","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110045_bib15","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2024.110045_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2024.110045_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn2055","article-title":"Regulatory mechanisms of AMPA receptors in synaptic plasticity","volume":"8","author":"Derkach","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib19","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.94.26.14843","article-title":"Very short-term plasticity in hippocampal synapses","volume":"94","author":"Dobrunz","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2024.110045_bib20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrn2969","article-title":"From glutamate co-release to vesicular synergy: vesicular glutamate transporters","volume":"12","author":"El Mestikawy","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib21","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.neuron.2021.05.026","article-title":"In vivo endocannabinoid dynamics at the timescale of physiological and pathological neural activity","volume":"109","author":"Farrell","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110045_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1755-5949.2010.00144.x","article-title":"Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders","volume":"16","author":"Fern\u00e1ndez-Ruiz","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2024.110045_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0896-6273(01)00344-0","article-title":"The expression of vesicular glutamate transporters defines two classes of excitatory synapse","volume":"31","author":"Fremeau","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110045_bib24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jpsychires.2010.01.006","article-title":"Interaction of childhood stress with hippocampus and prefrontal cortex volume reduction in major depression","volume":"44","author":"Frodl","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2024.110045_bib25","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/aur.2520","article-title":"Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-\u03b1, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL\/J mice","volume":"14","author":"Fyke","year":"2021","journal-title":"Autism Res."},{"key":"10.1016\/j.neuropharm.2024.110045_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pnpbp.2017.05.023","article-title":"Neurodevelopmental theory of depression","volume":"80","author":"Ga\u0142ecki","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2024.110045_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.762738","article-title":"Reviewing the role of the endocannabinoid system in the pathophysiology of depression","volume":"12","author":"Gallego-Landin","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib28","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1523\/JNEUROSCI.5693-09.2010","article-title":"Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice","volume":"30","author":"Gao","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-4328(97)81108-4","article-title":"Kindling of hippocampal field CA1 impairs spatial learning and retention in the Morris water maze","volume":"82","author":"Gilbert","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110045_bib30","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1073\/pnas.0505519103","article-title":"Recent behavioral history modifies coupling between cell activity and Arc gene transcription in hippocampal CA1 neurons","volume":"103","author":"Guzowski","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2024.110045_bib31","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1460-9568.2002.02192.x","article-title":"The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety","volume":"16","author":"Haller","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib32","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1523\/JNEUROSCI.21-21-08362.2001","article-title":"Paired-pulse plasticity at the single release site level: an experimental and computational study","volume":"21","author":"Hanse","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mce.2008.02.011","article-title":"Endocannabinoid functions controlling neuronal specification during brain development","volume":"286","author":"Harkany","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib34","doi-asserted-by":"crossref","first-page":"11781","DOI":"10.1523\/JNEUROSCI.1444-14.2014","article-title":"Vesicular glutamate transporter expression level affects synaptic vesicle release probability at hippocampal synapses in culture","volume":"34","author":"Herman","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2045-5380-3-19","article-title":"Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses","volume":"3","author":"Hill","year":"2013","journal-title":"Biol. Mood Anxiety Disord."},{"key":"10.1016\/j.neuropharm.2024.110045_bib36","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.npp.1300601","article-title":"Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress","volume":"30","author":"Hill","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.110045_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2007-993211","article-title":"Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report","volume":"41","author":"Hill","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuropharm.2024.110045_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109234","article-title":"Agmatine relieves behavioral impairments in Fragile X mice model","volume":"219","author":"Jeon","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110045_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms2045","article-title":"Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome","volume":"3","author":"Jung","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2024.110045_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13229-018-0203-y","article-title":"Plasma anandamide concentrations are lower in children with autism spectrum disorder","volume":"9","author":"Karhson","year":"2018","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuropharm.2024.110045_bib41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-neuro-062111-150420","article-title":"Multiple functions of endocannabinoid signaling in the brain","volume":"35","author":"Katona","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib42","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1523\/JNEUROSCI.4872-05.2006","article-title":"The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum","volume":"26","author":"Kawamura","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib43","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1460-9568.2004.03285.x","article-title":"Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity","volume":"19","author":"Khaspekov","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2014.01.013","article-title":"The role of DNA methylation in stress-related psychiatric disorders","volume":"80","author":"Klengel","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110045_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","article-title":"The Y-maze for assessment of spatial working and reference memory in mice","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbrc.2021.05.064","article-title":"Differential mechanisms of synaptic plasticity for susceptibility and resilience to chronic social defeat stress in male mice","volume":"562","author":"Lee","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2024.110045_bib47","first-page":"1","article-title":"Novel object recognition test for the investigation of learning and memory in mice","volume":"126","author":"Lueptow","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2024.110045_bib48","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005710","volume":"4","author":"L\u00fcscher","year":"2012","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02935552","article-title":"The role of postsynaptic calcium in the induction of long-term potentiation","volume":"5","author":"Malenka","year":"1991","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib50","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2024.110045_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/npp.2017.143","article-title":"The role of the endocannabinoid system and genetic variation in adolescent brain development","volume":"43","author":"Meyer","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.110045_bib52","series-title":"Enhanced Long-Term Potentiation and Impairedlearninginmicewithmutant Postsynaptic Density-95 Protein","first-page":"433","author":"Migaud","year":"1998"},{"key":"10.1016\/j.neuropharm.2024.110045_bib53","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/acer.14949","article-title":"2-Arachidonoylglycerol-mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice","volume":"46","author":"Morgan","year":"2022","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2024.110045_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2024.110045_bib55","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1601-183X.2004.00071.x","article-title":"Automated apparatus for quantitation of social approach behaviors in mice","volume":"3","author":"Nadler","year":"2004","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2024.110045_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101239","article-title":"Endocannabinoid signaling in adult hippocampal neurogenesis: a mechanistic and integrated perspective","volume":"91","author":"Oddi","year":"2023","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.neuropharm.2024.110045_bib57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1073\/pnas.1522364112","article-title":"Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition","volume":"113","author":"Ogasawara","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2024.110045_bib58","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1152\/jn.01052.2009","article-title":"Major impairments of glutamatergic transmission and long-term synaptic plasticity in the hippocampus of mice lacking the melanin-concentrating hormone receptor-1","volume":"104","author":"Pachoud","year":"2010","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib59","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2024.110045_bib60","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1007\/s12035-020-01912-7","article-title":"Molecular, structural, functional, and pharmacological sites for vesicular glutamate transporter regulation","volume":"57","author":"Pietrancosta","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib61","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1212\/WNL.57.9.1618","article-title":"Postmortem brain abnormalities of the glutamate neurotransmitter system in autism","volume":"57","author":"Purcell","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2024.110045_bib62","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00001756-199302000-00005","article-title":"Presence of cannabinoid binding sites in the brain from early postnatal ages","volume":"4","author":"Rodriguez de Fonseca","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2024.110045_bib63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuropharm.2019.02.026","article-title":"Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants","volume":"149","author":"Romero-Sanchiz","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110045_bib64","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.mp.4001949","article-title":"Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies","volume":"12","author":"Ruh\u00e9","year":"2007","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110045_bib65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-004-1877-8","article-title":"Reduced sensitivity to reward in CB1 knockout mice","volume":"176","author":"Sanchis-Segura","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2024.110045_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2017.00411","article-title":"Cannabinoid modulation of the stressed hippocampus","volume":"10","author":"Scarante","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib67","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1523\/JNEUROSCI.1353-18.2019","article-title":"Diacylglycerol lipase-alpha regulates hippocampal-dependent learning and memory processes in mice","volume":"39","author":"Schurman","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib68","first-page":"1","article-title":"Use of the open field maze to measure locomotor and anxiety-like behavior in mice","volume":"96","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2024.110045_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","article-title":"Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species","volume":"106\u2013107","author":"Semple","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib70","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1523\/JNEUROSCI.16-14-04322.1996","article-title":"Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures","volume":"16","author":"Shen","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nn.2708","article-title":"New views of Arc, a master regulator of synaptic plasticity","volume":"14","author":"Shepherd","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib72","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.celrep.2014.11.001","article-title":"Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation","volume":"9","author":"Shonesy","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2024.110045_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bcpt.13595","article-title":"Targeting 2-arachidonoylglycerol signalling in the neurobiology and treatment of depression","volume":"129","author":"Silveira","year":"2021","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib74","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1098\/rstb.2012.0313","article-title":"Endocannabinoids in nervous system health and disease: the big picture in a nutshell","volume":"367","author":"Skaper","year":"2012","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0187926","article-title":"Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans","volume":"12","author":"Smith","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.110045_bib76","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.tpj.6500466","article-title":"Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice","volume":"8","author":"Steiner","year":"2008","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.neuropharm.2024.110045_bib77","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.plipres.2006.03.003","article-title":"Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand","volume":"45","author":"Sugiura","year":"2006","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.neuropharm.2024.110045_bib78","first-page":"45","article-title":"Ketamine enhances visual sensory evoked potential long-term potentiation in patients with major depressive disorder","volume":"5","author":"Sumner","year":"2020","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.neuropharm.2024.110045_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00087","article-title":"Endocannabinoid modulation of microglial phenotypes in neuropathology","volume":"11","author":"Tanaka","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib80","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuron.2010.01.021","article-title":"The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase \u03b1 mediates retrograde suppression of synaptic transmission","volume":"65","author":"Tanimura","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110045_bib81","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0092-8674(00)81827-9","article-title":"The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory","volume":"87","author":"Tsien","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2024.110045_bib82","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrn1327","article-title":"Homeostatic plasticity in the developing nervous system","volume":"5","author":"Turrigiano","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110045_bib83","first-page":"1","article-title":"Inhibitory control of the excitatory\/inhibitory balance in psychiatric disorders","volume":"7","author":"van Bokhoven","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.neuropharm.2024.110045_bib84","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2003.08.101","article-title":"The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders","volume":"480","author":"Van Der Stelt","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib86","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1038\/s41380-020-00905-1","article-title":"Role of endocannabinoid signaling in a septohabenular pathway in the regulation of anxiety- and depressive-like behavior","volume":"26","author":"Vickstrom","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110045_bib87","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neuroscience.2004.02.003","article-title":"Blockade of N-methyl-D-aspartate receptors by phencyclidine causes the loss of corticostriatal neurons","volume":"125","author":"Wang","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110045_bib88","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1471-4159.1997.68020469.x","article-title":"NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins","volume":"68","author":"Wenzel","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2024.110045_bib89","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/npp.2014.24","article-title":"Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling","volume":"39","author":"Zhong","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.110045_bib90","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1152\/jn.00327.2009","article-title":"Developmental alteration of endocannabinoid retrograde signaling in the hippocampus","volume":"103","author":"Zhu","year":"2010","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2024.110045_bib91","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev.ne.12.030189.000305","article-title":"Short-term synaptic plasticity","volume":"12","author":"Zucker","year":"1989","journal-title":"Annu. Rev. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824002144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824002144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T12:36:38Z","timestamp":1728131798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824002144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":90,"alternative-id":["S0028390824002144"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110045","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal dysregulation of 2-arachidonoylglycerol induces impaired brain function in adult mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110045"}}